drugset / Trial / NCT00456729

Malabsorption as a Cause of Iron Treatment Failure in Infants

NCT00456729

Completed 100 enrolled HaEmek Medical Center, Israel
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment. The purpose of this study is to assess the incidence of malabsorption in those infants and to examine the results of empiric treatment with metronidazole.

Timeline

Start
2006-05
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule